Program
GB-0895
A development code. Also written as “GB-0895 (SC)”.
Its studies are mostly in Asthma, led by Generate Biomedicines.
Furthest: phase 3, since Dec 1, 20253 company-led studies, 3 open or runningNext primary completion: May 2027 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Generate Biomedicines | 33 open or running | phase 3since Dec 1, 2025 | Jul 23, 2025 | May 2027phase 1 · NCT07116889 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 23, 2025First study: phase 1 study in AsthmaFirst studyNCT07116889 · 156 enrolled · United States, Germany, United Kingdom
- Dec 1, 2025Phase 3 study in AsthmaPhase 3 reachedNCT07276724 · 786 planned · United States, Brazil, Bulgaria and more
- Jan 21, 2026Phase 3 study in AsthmaNCT07359846 · 786 planned · United States, Argentina, Australia and more
Ahead
- May 2027Primary completion: phase 1 study in AsthmaNCT07116889
- Dec 2028Primary completion: phase 3 study in AsthmaNCT07276724
- Jan 2029Primary completion: phase 3 study in AsthmaNCT07359846
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07359846Asthma · United States, Argentina, Australia and more | 3 | Recruiting | Jan 2029 | 786 |
| NCT07276724Asthma · United States, Brazil, Bulgaria and more | 3 | Recruiting | Dec 2028 | 786 |
| NCT07116889Asthma · United States, Germany, United Kingdom | 1 | Active, not recruiting | May 2027 | 156 |
How it is read
Names in the registry
- “GB-0895”, 2 entries
- “GB-0895 (SC)”, 2 entries
Codes read as this program: GB0895.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.